Cargando…

Immunoparesis in newly diagnosed Multiple Myeloma patients: Effects on overall survival and progression free survival in the Danish population

Immunoparesis (hypogammaglobulinemia) is associated to an unfavorable prognosis in newly diagnosed Multiple myeloma (MM) patients. However, this finding has not been validated in an unselected population-based cohort. We analyzed 2558 newly diagnosed MM patients in the Danish Multiple Myeloma Regist...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sørrig, Rasmus, Klausen, Tobias W., Salomo, Morten, Vangsted, Annette J., Frølund, Ulf Christian, Andersen, Kristian T., Klostergaard, Anja, Helleberg, Carsten, Pedersen, Robert S., Pedersen, Per T., Helm-Petersen, Sissel, Teodorescu, Elena Manuela, Preiss, Birgitte, Abildgaard, Niels, Gimsing, Peter
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5720701/ https://www.ncbi.nlm.nih.gov/pubmed/29216227 http://dx.doi.org/10.1371/journal.pone.0188988

Ejemplares similares

The impact of comorbidity on mortality in multiple myeloma: a Danish nationwide population‐based study
por: Gregersen, Henrik, et al.
Publicado: (2017)

The Danish National Multiple Myeloma Registry
por: Gimsing, Peter, et al.
Publicado: (2016)

Characterisation of immunoparesis in newly diagnosed myeloma and its impact on progression-free and overall survival in both old and recent myeloma trials
por: Heaney, Jennifer L. J., et al.
Publicado: (2018)

Clinical Considerations for Immunoparesis in Multiple Myeloma
por: Chahin, Michael, et al.
Publicado: (2022)

Inflammation-scores as prognostic markers of overall survival in lung cancer: a register-based study of 6,210 Danish lung cancer patients
por: Winther-Larsen, Anne, et al.
Publicado: (2022)

The Impact of the COVID-19 Pandemic on Quality of Life in Danish Patients with Multiple Myeloma; Results from an Ongoing Longitudinal National Survey
por: Redder, Louise, et al.
Publicado: (2021)

Characterisation and prognostic impact of immunoparesis in relapsed multiple myeloma
por: Chakraborty, Rajshekhar, et al.
Publicado: (2020)

Incidence and clinical characteristics of multiple myeloma with low M-protein levels and normal values of hemoglobin, creatinine, calcium, and serum free light chain ratio
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

Partial immunoparesis contributes to risk of early infections in patients with multiple myeloma
por: Huang, Weimin, et al.
Publicado: (2021)

No influence of the polymorphisms CYP2C19 and CYP2D6 on the efficacy of cyclophosphamide, thalidomide, and bortezomib in patients with Multiple Myeloma
por: Vangsted, Annette J, et al.
Publicado: (2010)

Physical function in patients newly diagnosed with multiple myeloma; a Danish cohort study
por: Larsen, Rikke Faebo, et al.
Publicado: (2020)

A randomized placebo-controlled phase II study of clarithromycin or placebo combined with VCD induction therapy prior to high-dose melphalan with stem cell support in patients with newly diagnosed multiple myeloma
por: Gregersen, Henrik, et al.
Publicado: (2018)

Geographical and ecological analyses of multiple myeloma in Denmark: Identification of potential hotspot areas and impact of urbanisation
por: Bertelsen, Lise Dueholm, et al.
Publicado: (2022)

Low-pathogenicity mycoplasma species induce immunoparesis and are highly prevalent amongst patients with ventilator-associated pneumonia
por: Nolan, TJ, et al.
Publicado: (2015)

β-Blocker Therapy and Risk of Chronic Obstructive Pulmonary Disease – A Danish Nationwide Study of 1·3 Million Individuals
por: Nielsen, Anne Orholm, et al.
Publicado: (2019)

Prediction of survival in amyotrophic lateral sclerosis: a nationwide, Danish cohort study
por: Kjældgaard, Anne-Lene, et al.
Publicado: (2021)

Two Decades of Cardiac Amyloidosis: A Danish Nationwide Study
por: Westin, Oscar, et al.
Publicado: (2021)

Strategies to improve patient-reported outcome completion rates in longitudinal studies
por: Nielsen, Lene Kongsgaard, et al.
Publicado: (2019)

The real-world outcomes of multiple myeloma patients treated with daratumumab
por: Szabo, Agoston Gyula, et al.
Publicado: (2021)

Carfilzomib and dexamethasone maintenance following salvage ASCT in multiple myeloma: A randomised phase 2 trial by the Nordic Myeloma Study Group
por: Gregersen, Henrik, et al.
Publicado: (2021)

Plasma Kallikrein-Activated TGF-β Is Prognostic for Poor Overall Survival in Patients with Pancreatic Ductal Adenocarcinoma and Associates with Increased Fibrogenesis
por: Pedersen, Rasmus S., et al.
Publicado: (2022)

Long-Term Temporal Trends in Survival Among Danish Patients with Advanced Cutaneous Melanoma: A Nationwide Follow-Up Study
por: Pedersen, Alma B, et al.
Publicado: (2023)

Up-front fludarabine impairs stem cell harvest in multiple myeloma: report from an interim analysis of the NMSG 13/03 randomized placebo controlled phase II trial
por: Johnsen, Hans E, et al.
Publicado: (2009)

The impact of previous cancer on overall survival of bladder cancer patients and the establishment of nomogram for overall survival prediction
por: Wang, Zhengquan, et al.
Publicado: (2020)

Potential value of pre-planned imaging of bone disease in multiple myeloma
por: Gundesen, Michael T., et al.
Publicado: (2023)

Incidence and Overall Survival of Malignant Ameloblastoma
por: Rizzitelli, Alexandra, et al.
Publicado: (2015)

Danish National Lymphoma Registry
por: Arboe, Bente, et al.
Publicado: (2016)

The Danish Sarcoma Database
por: Jørgensen, Peter Holmberg, et al.
Publicado: (2016)

Peyronie’s disease questionnaire: translation into Danish and cultural adaptation
por: Wiborg, Majken H, et al.
Publicado: (2023)

Linkage between the Danish National Health Service Prescription Database, the Danish Fetal Medicine Database, and other Danish registries as a tool for the study of drug safety in pregnancy
por: Pedersen, Lars H, et al.
Publicado: (2016)

Single-cell and bulk RNA sequencing reveal ligands and receptors associated with worse overall survival in serous ovarian cancer
por: Carvalho, Robson Francisco, et al.
Publicado: (2022)

Collagen Biomarkers Quantify Fibroblast Activity In Vitro and Predict Survival in Patients with Pancreatic Ductal Adenocarcinoma
por: Nissen, Neel I., et al.
Publicado: (2022)

Is there hope in improving 5-year overall survival?—review of 5-year overall survival data from KEYNOTE-001
por: Akingbemi, Wisdom, et al.
Publicado: (2020)

Cohort description: The Danish study of Functional Disorders
por: Dantoft, Thomas Meinertz, et al.
Publicado: (2017)

In Vitro Palmitate Treatment of Myotubes from Postmenopausal Women Leads to Ceramide Accumulation, Inflammation and Affected Insulin Signaling
por: Abildgaard, Julie, et al.
Publicado: (2014)

Perioperative FLOT chemotherapy plus surgery for oligometastatic esophagogastric adenocarcinoma: surgical outcome and overall survival
por: Runkel, Mira, et al.
Publicado: (2021)

Salvage bortezomib–dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial
por: Gimsing, P, et al.
Publicado: (2015)

Physical Activity as an Effect Modifier of the Association Between Obesity and Venous Thromboembolism: A Danish Population-Based Cohort Study
por: Solli, Henrik, et al.
Publicado: (2020)

Nomograms to predict overall survival and cancer-specific survival in patients with adrenocortical carcinoma
por: Li, Yan, et al.
Publicado: (2018)

Nomograms predicting overall survival and cancer-specific survival in osteosarcoma patients (STROBE)
por: Chen, Wenhao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_2i5abv8amd457mm178s6sip17l